Impact of fentanyl use on initiation and discontinuation of methadone and buprenorphine/naloxone among people with prescription‐type opioid use disorder: secondary analysis of a Canadian treatment trial-Reference-Cited by-同舟云学术

Impact of fentanyl use on initiation and discontinuation of methadone and buprenorphine/naloxone among people with prescription‐type opioid use disorder: secondary analysis of a Canadian treatment trial

Published:2022-06-17 Issue:10 Volume:117 Page:2662-2672
ISSN:0965-2140
Container-title:Addiction
language:en
Short-container-title:Addiction

Author:

Socias M. Eugenia¹²^ORCID,Wood Evan¹²,Le Foll Bernard³⁴⁵⁶⁷,Lim Ron⁸,Choi Jin Cheol¹,Mok Wing Yin¹,Bruneau Julie⁹¹⁰^ORCID,Rehm Jürgen⁵⁶¹¹¹²¹³^ORCID,Wild T. Cameron¹⁴^ORCID,Bozinoff Nikki⁴⁷,Hassan Ahmed³⁵⁷^ORCID,Jutras‐Aswad Didier⁹¹⁵^ORCID,

Affiliation:

1. British Columbia Centre on Substance Use Vancouver BC Canada

2. Department of Medicine, Faculty of Medicine University of British Columbia Vancouver BC Canada

3. Department of Pharmacology and Toxicology, Faculty of Medicine, Medical Sciences Building University of Toronto Toronto ON Canada

4. Department of Family and Community Medicine, Faculty of Medicine University of Toronto Toronto ON Canada

5. Department of Psychiatry University of Toronto Toronto ON Canada

6. Dalla Lana School of Public Health University of Toronto Toronto ON Canada

7. Campbell Family Mental Health Research Institute Center for Addiction and Mental Health (CAMH) Toronto ON Canada

8. Department of Family Medicine and Psychiatry, Cumming School of Medicine University of Calgary Calgary AB Canada

9. Research Centre Centre Hospitalier de l’Université de Montréal (CRCHUM) Montréal QC Canada

10. Department of Family and Emergency Medicine, Faculty of Medicine Université de Montréal Montréal QC Canada

11. Institute for Mental Health Policy Research, CAMH Toronto ON Canada

12. Institute of Clinical Psychology and Psychotherapy Centre and Centre for Clinical Epidemiology and Longitudinal Studies Technische Universität Dresden Dresden Germany

13. Department of International Health Projects, Institute for Leadership and Health Management I.M. Sechenov First Moscow State Medical University Moscow Russia

14. School of Public Health University of Alberta Edmonton AB Canada

15. Department of Psychiatry and Addictology, Faculty of Medicine Université de Montréal Montréal QC Canada

Funder

Canadian Institutes of Health Research

Publisher

Wiley

Subject

Psychiatry and Mental health,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/add.15954

Reference32 articles.

1. The Deepening Opioid Crisis in North America: Historical Context and Current Solutions

2. Special Advisory Committee on the Epidemic of Opioid Overdoses.Opioids and Stimulant‐related Harms in Canada. Public Health Agency of Canada. Available at:https://health-infobase.canada.ca/substance-related-harms/opioids-stimulantsAccessed 7 October 2021.

3. AhmadF RossenL SuttonP.Provisional drug overdose death counts. National Center for Health Statistics. Available at:https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htmAccessed 7 October 2021.

4. Management of opioid use disorders: a national clinical practice guideline

5. Opioid agonist treatment and risk of mortality during opioid overdose public health emergency: population based retrospective cohort study

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlates of nonfatal overdose among treatment-seeking individuals with non-heroin opioid use disorder: Findings from a pragmatic, pan-Canadian, randomized control trial;Journal of Substance Use and Addiction Treatment;2023-12

2. Endogenous opiates and behavior: 2022;Peptides;2023-11

3. The Association Between Self-Reported Anxiety and Retention in Opioid Agonist Therapy: Findings From a Canadian Pragmatic Trial;The Canadian Journal of Psychiatry;2023-09-12

4. Differential effect of cannabis use on opioid agonist treatment outcomes: Exploratory analyses from the OPTIMA study;Journal of Substance Use and Addiction Treatment;2023-06

5. Antecedents of fatal overdose in an adult cohort identified through administrative record linkage in Indiana, 2015–2022;Drug and Alcohol Dependence;2023-06